Adjusted Indirect Comparison Between Epcoritamab‐R 2 and Tafasitamab‐R 2 in Relapse/Refractory Follicular Lymphoma
Year: 2026
Type: article
Source: Hematological Oncology
DOI: 10.1002/hon.70282
Institutions: University of Ioannina, University Hospital of Ioannina
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7223471468
